MedPath

The Augmented Versus Routine Approach to Giving Energy Trial

Phase 3
Completed
Conditions
Critical Illness
Interventions
Dietary Supplement: TARGET protocol EN 1.0 kcal/mL
Dietary Supplement: TARGET protocol EN 1.5 kcal/mL
Registration Number
NCT02306746
Lead Sponsor
Australian and New Zealand Intensive Care Research Centre
Brief Summary

Nutrition therapy is an essential standard of care for all critically ill patients who are mechanically ventilated and remain in the intensive care unit for more than a few days.

The investigators plan to conduct a 4,000 patient, double-blind, randomised controlled trial to determine if augmentation of calorie delivery using energy dense enteral nutrition in mechanically ventilated patients improves 90 day survival when compared to routine care.

Detailed Description

Each year around 130,000 Australians are admitted to ICU at a daily cost of approximately $4000 per patient. Their care consumes close to 3 billion dollars per year. These critically ill patients are the sickest in the hospital. They require substantial resources and multiple interventions. Some die and many of those who survive have delayed and compromised functional recovery which can persist for months or years.

Nutrition therapy is an essential standard of care for all ICU patients who are mechanically ventilated and remain in ICU for more than a few days. Enteral nutrition (via a nasogastric tube) is usually initiated within 24 hours of ICU admission with a formula containing 1 kcal/ml and prescribed at an approximate rate of 1 ml/kg/hour. However, standard enteral nutrition practice typically results in the delivery of only \~60% of the full-recommended calorie requirement.

Although prescribed calories can reliably be delivered using the intravenous route, the enteral route is preferred for a number of reasons and is recommended by all nutrition guidelines as first-line therapy. In particular, enteral nutrition is more physiological, less costly and associated with fewer infective complications. Delivery of nutrient into the gut also has beneficial effects on subsequent gut function and may reduce ongoing sepsis which can be fuelled by the movement of gut flora through a permeable mucosa that has not been exposed to nutrient. Intravenous nutrition is accordingly, generally used only when enteral feeding is impossible, or persistently limited. Although supplementing enteral with intravenous nutrition can increase calorie delivery, this has not been shown to have a therapeutic benefit and may worsen important clinical outcomes. This may be because adverse effects associated with intravenous nutrition counteract the benefits of increased calorie delivery.

Previous trials support the concept that optimising nutrition in the critically ill will improve outcome, however, the evidence is limited, inclusive and generally of low quality. It is extraordinary that there is not better (Level I) evidence to inform nutrition management in critically ill patients given the frequency of the intervention, the biologic rationale, the high mortality following ICU admission, the frequency of muscle wasting and the poor functional outcomes in survivors. This is especially true given the low cost of enteral nutrition (\~$23/day).

The investigators recently completed pilot study clearly achieved all the key criteria which, for a pharmaceutical product, would lead to a phase III trial, namely: 1. feasibility; 2. safety; 3. separation; 4. excellent recruitment rate; 5. successful blinding; 6. a signal for benefit.

A definitive study must now be done to establish whether 90-day survival and functional outcomes following critical illness may be improved by increased calorie delivery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4000
Inclusion Criteria
  • Intubated and receiving mechanical ventilation
  • About to commence enteral nutrition or enteral nutrition commenced within the previous12 hours
  • Expected to be receiving enteral nutrition in ICU until at least the day after tomorrow
Exclusion Criteria
  • Any Enteral Nutrition (EN) or Parenteral Nutrition (PN) received for >12 hours in this ICU admission
  • Treating clinician considers the EN goal rate (i.e.1ml/kg of ideal body weight per hour) to be clinically contraindicated e.g. requirement for fluid restriction
  • Requirement for specific nutritional therapy as determined by the treating doctor or dietitian i.e. TARGET protocol EN not considered to be in the best interest of the patient
  • Death is deemed to be imminent or inevitable during this admission and either the attending physician, patient or substitute decision maker is not committed to active treatment
  • The patient has an underlying disease that makes survival to 90 days unlikely
  • ≥ 15% burns
  • Previously enrolled in this study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TARGET protocol EN 1.0 kcal/mLTARGET protocol EN 1.0 kcal/mLEnteral feed 1.0 kcal/mL The goal rate for administration of TARGET protocol EN is 1ml/kg/hr. To calculate the goal rate, weight is based on ideal body weight.
TARGET protocol EN 1.5 kcal/mLTARGET protocol EN 1.5 kcal/mLEnteral (EN) feed 1.5 kcal/mL. The goal rate for administration of TARGET protocol EN is 1ml/kg/hr. To calculate the goal rate, weight is based on ideal body weight.
Primary Outcome Measures
NameTimeMethod
All cause mortalityDay 90

Mortality status

Secondary Outcome Measures
NameTimeMethod
Time from randomisation until deathDay 180

Mortality status

MortalityDay 180

Mortality status

Number of days alive and not in ICUDay 28

Mortality status

Number of days alive and not in hospitalDay 28

Mortality status

Quality of life assessmentDay 180

European Quality of Life 5 Dimensions

Ventilator free daysDay 28

Organ support status

Vasopressor free daysDay 28

Organ support status

Proportion of patients receiving any renal replacement therapyDay 28

Organ support proportion

Renal replacement therapy free daysDay 28

Organ support status

Functional outcomes for patients under 65 years in the work forceDay 180

Questions from the Australian Labour Force Survey

Functional outcomes for patients under 65 years and not in the work force and patients 65 years and over living dependentlyDay 180

World Health Organization Disability Assessment Schedule 2.0

Cause-specific mortalityDay 90

Mortality status

Proportion of patients receiving vasopressor supportDay 28

Organ support proportion

Proportion of patients with positive blood culturesDay 28

Blood stream infection proportion

Proportion of patients requiring intravenous antimicrobialsDay 28

Patients requiring intravenous antimicrobials

Functional outcomes for patients 65 years and over living independentlyDay 180

Adelaide Activities Profile

Trial Locations

Locations (46)

Gosford Hospital

🇦🇺

Gosford, New South Wales, Australia

Canberra Hospital

🇦🇺

Canberra, Australian Capital Territory, Australia

Royal Brisbane and Women's Hospital

🇦🇺

Brisbane, Queensland, Australia

Princess Alexandra Hospital

🇦🇺

Brisbane, Queensland, Australia

Logan Hospital

🇦🇺

Brisbane, Queensland, Australia

Monash Health Dandenong Hospital

🇦🇺

Melbourne, Victoria, Australia

Bunbury Hospital

🇦🇺

Bunbury, Western Australia, Australia

North Shore Hospital

🇳🇿

Auckland, New Zealand

Auckland City Hospital Department of Critical Care Medicine

🇳🇿

Auckland, New Zealand

Auckland City Hospital Cardiovascular Intensive Care Unit

🇳🇿

Auckland, New Zealand

Middlemore Hospital

🇳🇿

Auckland, New Zealand

Christchurch Hospital

🇳🇿

Christchurch, New Zealand

Waikato Hospital

🇳🇿

Hamilton, New Zealand

Hutt Valley Hospital

🇳🇿

Lower Hutt, New Zealand

Hawkes Bay Fallen Soldiers Memorial Hospital

🇳🇿

Hastings, New Zealand

Nelson Hospital

🇳🇿

Nelson, New Zealand

Rotorua Hospital

🇳🇿

Rotorua, New Zealand

Tauranga Hospital

🇳🇿

Tauranga, New Zealand

Wellington Regional Hospital

🇳🇿

Wellington, New Zealand

Royal Hobart Hospital

🇦🇺

Hobart, Tasmania, Australia

Bendigo Hospital

🇦🇺

Bendigo, Victoria, Australia

Footscray Hospital

🇦🇺

Footscray, Victoria, Australia

Frankston Hosptial

🇦🇺

Frankston, Victoria, Australia

University Hosptial Geelong

🇦🇺

Geelong, Victoria, Australia

Austin Hospital

🇦🇺

Heidelberg, Victoria, Australia

Sunshine Hospital

🇦🇺

Melbourne, Victoria, Australia

Royal Melbourne Hospital

🇦🇺

Melbourne, Victoria, Australia

St Vincent's Hospital Melbourne

🇦🇺

Melbourne, Victoria, Australia

St Vincent's Hospital Sydney

🇦🇺

Sydney, New South Wales, Australia

Royal North Shore Hosptial

🇦🇺

Sydney, New South Wales, Australia

Sydney Adventist Hospital

🇦🇺

Sydney, New South Wales, Australia

Concord Hospital

🇦🇺

Sydney, New South Wales, Australia

Westmead Hospital

🇦🇺

Sydney, New South Wales, Australia

Blacktown Hospital

🇦🇺

Sydney, New South Wales, Australia

Liverpool Hospital

🇦🇺

Sydney, New South Wales, Australia

St George Hospital

🇦🇺

Sydney, New South Wales, Australia

Nepean Hospital

🇦🇺

Sydney, New South Wales, Australia

Royal Prince Alfred Hospital

🇦🇺

Sydney, New South Wales, Australia

Royal Adelaide Hosptial

🇦🇺

Adelaide, South Australia, Australia

Queen Elizabeth Hospital

🇦🇺

Adelaide, South Australia, Australia

Lyell McEwin

🇦🇺

Adelaide, South Australia, Australia

Sir Charles Gairdner Hospital

🇦🇺

Perth, Western Australia, Australia

St John of God Hospital Murdoch

🇦🇺

Perth, Western Australia, Australia

Fiona Stanley Hospital

🇦🇺

Perth, Western Australia, Australia

Toowoomba Hospital

🇦🇺

Toowoomba, Queensland, Australia

Launceston General Hospital

🇦🇺

Launceston, Tasmania, Australia

© Copyright 2025. All Rights Reserved by MedPath